Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause White blood cell count increased? 98 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 98 reports of White blood cell count increased have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.3% of all adverse event reports for ROSUVASTATIN.

98
Reports of White blood cell count increased with ROSUVASTATIN
0.3%
of all ROSUVASTATIN reports
4
Deaths
57
Hospitalizations

How Dangerous Is White blood cell count increased From ROSUVASTATIN?

Of the 98 reports, 4 (4.1%) resulted in death, 57 (58.2%) required hospitalization, and 4 (4.1%) were considered life-threatening.

Is White blood cell count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 98 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause White blood cell count increased?

CLOZAPINE (2,988) ADALIMUMAB (1,710) RUXOLITINIB (1,529) IBRUTINIB (1,390) RITUXIMAB (886) METHOTREXATE (741) PREDNISONE (716) ETANERCEPT (615) IMATINIB (520) TOCILIZUMAB (478)

Which ROSUVASTATIN Alternatives Have Lower White blood cell count increased Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All White blood cell count increased Reports All Drugs Causing White blood cell count increased ROSUVASTATIN Demographics